Tempus (Tem Stock): Tempus is a technology company that uses AI and data science to advance precision medicine, particularly in oncology. By analyzing clinical, molecular and genetic data, they help physicians make personalized treatment decisions. Their work involves genomic sequencing, clinical trial matching and decision support, collaborating with hospitals and pharmaceutical companies to improve patient care and accelerate research. The future stock price forecasts depend on a variety of factors, such as market conditions, company performance and industry trends, and it is also based on detailed financial analysis.
TEM Company Overview
| Company Name | Tempus AI, Inc. |
| Founded | 2015 |
| Headquarters | Chicago, Illinois, United States |
| Industry | Health technology |
| CEO | Eric Lefkofsky |
| Stock Exchange Listing | Nasdaq:Â TEM |
| Official Website | www.tempus.com |
TEM AI Fundamental Analysis
| Metric | Value |
|---|---|
| Market Cap | $7.53B |
| ROE | – |
| ROCE | – |
| P/E | -191.56 |
| P/B | 12.6 |
| Div. Yield | 0.00% |
| Book Value | $0.35 |
| EPS (TTM) | $-5.16 |
| 52 Week High | $79.49 |
| 52 Week Low | $22.89 |
Also Read: Broadcom Stock Price Forecast
TEM AI Financials
Income Statement
| USD | 2023 | Y/Y Change |
|---|---|---|
| Revenue | 531.82M | 65.85% |
| Operating Expense | 475.30M | 19.02% |
| Net Income | -214.12M | 26.12% |
| Net Profit Margin | -40.26 | 55.45% |
| Earnings Per Share | — | — |
| EBITDA | -155.79M | 34.74% |
| Effective Tax Rate | -0.13% | — |
Balance Sheet
| USD | 2023 | Y/Y Change |
|---|---|---|
| Cash and Short-term Investments | 197.57M | -34.78% |
| Total Assets | 564.05M | -10.66% |
| Total Liabilities | 840.67M | 14.49% |
| Total Equity | -276.62M | — |
| Shares Outstanding | 63.43M | — |
| Price to Book | -1.61 | — |
| Return on Assets | -19.78% | — |
| Return on Capital | -43.64% | — |
Cash Flow
| USD | 2023 | Y/Y Change |
|---|---|---|
| Net Income | -214.12M | 26.12% |
| Cash from Operations | -214.34M | -27.43% |
| Cash from Investing | -40.31M | 30.42% |
| Cash from Financing | 117.55M | -53.24% |
| Net Change in Cash | -137.12M | -642.74% |
| Free Cash Flow | -105.90M | 15.54% |
Also Read: NVIDIA Stock Price: Prediction
TEM Stock Price Prediction From 2025 to 2030
| Year | Target Price |
|---|---|
| TEM Stock Price Prediction​ 2025 | $58 |
| TEM AI Price Prediction 2026 | $76 |
| TEM Stock Price Prediction 2027 | $92 |
| TEM AI Price Prediction 2028 | $117 |
| TEM AI Price Prediction 2029 | $185 |
| TEM Stock Price Prediction 2030 | $290 |
TEM AI Top Shareholders
| Company | % of Total |
|---|---|
| Softbank Group Corporation | 3.55% |
| NEA Management Company, LLC | 3.53% |
| Price (T.Rowe) Associates Inc | 3.38% |
| Novo Holdings A/S | 2.67% |
| Revolution Growth Management Company, Inc. | 2.40% |
| ARK Investment Management, LLC | 1.56% |
| Alphabet Inc. | 1.02% |
| Millennium Management Llc | 0.98% |
| Sumitomo Mitsui Trust Holdings, Inc. | 0.80% |
| Nikko Asset Management Americas, Inc. | 0.80% |
Also Read: Tesla Stock Price Forecast
TEM AI Competitors/Peer Companies
- Check Point Software Technologies
- MongoDB
- Snap
- DocuSign
- Nutanix
- Twilio
- Gen Digital
- Duolingo
- CyberArk Software
Also Read: VST Stock Forecast &Â Price Prediction
To connect with us, click on any of the given social media buttons.
FAQs
-
What is the Tem AI Stock Price Target 2025?
58 USD.
-
What is the Tem AI Stock Price Target 2026?
76 USD.
-
What is the Tem AI Stock Price Target 2027?
92 USD.
-
What is the Tem AI Stock Price Target 2029?
185 USD.
-
What is the Tem AI Stock Price Target 2030?
290 USD.
Disclaimer: The information in this blog is for educational purposes only, and the targets mentioned in it are given as suggestions by market analysts. Therefore, before investing your money in any company, it is mandatory to get complete information about the company and consult your financial advisor.
With 5.5 years of experience in financial journalism, I am a content writer who specializes in international markets. My aim is always to deliver unbiased and factual reporting.